Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2008; 14(21): 3350-3359
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3350
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3350
PSC | AIP-SC | |
Gender | M:F = 2:1 | Probably some male predominance[818587] |
Clinical presentation | Usually insidious. Sometimes with obstructive jaundice secondary to cholangiocarcinoma. | Mild abdo/Back pain |
Sometimes with short history of obstructive jaundice due to CBD stricture | ||
Associated inflammatory bowel disease | Yes | No |
Cholangiographic findings | Diffuse changes throughout intra- and extrahepatic bile ducts. Abnormalities in pancreatic duct common. | Pancreatic duct strictures or narrowing. Often stricture of distal 1/3 of common bile duct. Intrahepatic duct changes less common. |
Blood chemistry data | Often cholestatic but bilirubin usually near normal. | May be cholestatic. Bilirubin often high |
Autoantibodies | Atypical pANCA plus range of others | Antibodies to carbonic anhydrase II plus range of others[808184] |
Immunoglobulins | IgG4 levels normal | IgG4 levels usually elevated[82] |
Histology | Absence of plasma cells positive for IgG4 on immunostaining | IgG4 positive plasma cells present in bile ducts and portal tracts[79] |
Liver biopsy staging | Range of Ludwig staging including higher stages eg III or IV | Ludwig staging usually only I or II[86] |
Treatment | Ursodeoxycholic acid ± biliary drainage for dominant strictures | Systemic steroid therapy usually leads to complete resolution of symptoms and signs of disease. Occasionally patients relapse and require longer courses of steroids |
- Citation: Chapman R, Cullen S. Etiopathogenesis of primary sclerosing cholangitis. World J Gastroenterol 2008; 14(21): 3350-3359
- URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3350.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3350